Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitsuhiko Moriyama

Showing results (1-10 of 212) with videos related to

Pageof 22
Sort By:
World Journal of Gastroenterology|September 9, 2017
Direct-acting antiviral agents against hepatitis C virus and lipid metabolismTatsuo Kanda, Mitsuhiko Moriyama
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|March 26, 2008
[Chronic viral hepatitis: clinical test values and interpretation of viral markers]Hiroshi Matsumura, Mitsuhiko Moriyama
Expert Opinion on Pharmacotherapy|May 31, 2006
Treatment of interferon-alpha for chronic hepatitis CMitsuhiko Moriyama, Yasuyuki Arakawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 6, 2016
[A diagnosis and treatment of the hepatitis E]Akinori Tamura, Mitsuhiko Moriyama
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 30, 2004
[Detection of SEN-V]Miki Kaneko, Yasuyuki Arakawa, Mitsuhiko Moriyama
Hepatology International|July 12, 2018
Hepatitis C virus genotype 4-infection and interferon-free treatment in EgyptTatsuo Kanda, Shunichi Matsuoka, Mitsuhiko Moriyama
Hepatobiliary Surgery and Nutrition|September 7, 2019
Are direct-acting antivirals against hepatitis C virus infection not associated with the recurrence of hepatocellular carcinoma?Masahiro Ogawa, Tatsuo Kanda, Mitsuhiko Moriyama
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 14, 2004
[Incidence and clinical statistics in HCV antibody-positive liver cirrhosis]Mitsuhiko Moriyama, Yasuyuki Arakawa, Atsuo Shioda
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 22, 2005
[Magnesium (Mg)]Yasuyuki Arakawa, Mitsuhiko Moriyama, Yasuo Arakawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 22, 2010
[Gastrin]Hideki Sato, Teruaki Matsui, Mitsuhiko Moriyama
Pageof 22

Showing results (1-10 of 212) with videos related to

Sort By:
Pageof 22
World Journal of Gastroenterology|September 9, 2017
Direct-acting antiviral agents against hepatitis C virus and lipid metabolismTatsuo Kanda, Mitsuhiko Moriyama
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|March 26, 2008
[Chronic viral hepatitis: clinical test values and interpretation of viral markers]Hiroshi Matsumura, Mitsuhiko Moriyama
Expert Opinion on Pharmacotherapy|May 31, 2006
Treatment of interferon-alpha for chronic hepatitis CMitsuhiko Moriyama, Yasuyuki Arakawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 6, 2016
[A diagnosis and treatment of the hepatitis E]Akinori Tamura, Mitsuhiko Moriyama
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 30, 2004
[Detection of SEN-V]Miki Kaneko, Yasuyuki Arakawa, Mitsuhiko Moriyama
Hepatology International|July 12, 2018
Hepatitis C virus genotype 4-infection and interferon-free treatment in EgyptTatsuo Kanda, Shunichi Matsuoka, Mitsuhiko Moriyama
Hepatobiliary Surgery and Nutrition|September 7, 2019
Are direct-acting antivirals against hepatitis C virus infection not associated with the recurrence of hepatocellular carcinoma?Masahiro Ogawa, Tatsuo Kanda, Mitsuhiko Moriyama
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 14, 2004
[Incidence and clinical statistics in HCV antibody-positive liver cirrhosis]Mitsuhiko Moriyama, Yasuyuki Arakawa, Atsuo Shioda
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 22, 2005
[Magnesium (Mg)]Yasuyuki Arakawa, Mitsuhiko Moriyama, Yasuo Arakawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 22, 2010
[Gastrin]Hideki Sato, Teruaki Matsui, Mitsuhiko Moriyama
Pageof 22